TTrialPathMatch Me to Trials
← Back to trials
RecruitingDiabetic Peripheral Neuropathic Pain

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

Eligible age

18–80 yrs

Accepts

All genders

Locations

31 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabetic peripheral neuropathy (DPN).

Sponsor: Vertex Pharmaceuticals Incorporated

Where it's recruiting

Alabama

Anniston · Birmingham · Daphne

Arizona

Phoenix · Scottsdale

California

Fresno · Long Beach · Los Angeles · Pomona …

Colorado

Englewood

District of Columbia

Washington D.C.

Florida

DeLand · Doral · Fort Myers · Hallandale …

Georgia

Decatur

Idaho

Meridian

Illinois

Chicago · Flossmoor

Indiana

Evansville

Kansas

Wichita

Kentucky

Lexington

Source: ClinicalTrials.gov · NCT06628908 · last updated 2026-10-15

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated W · TrialPath